Estimation of the Effect of Multiple Dose Ritlecitinib (PF-06651600) on the Pharmacokinetics of a Single Dose of Caffeine in Healthy Participants
Clinical trial NCT04655040 · COMPLETED
Trial details
- NCT number
- NCT04655040
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-18
- Primary completion
- 2021-03-05
- Enrollment
- 12
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.